Health
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18, a Potential Game-Changing saRNA Therapeutic for Duchenne Muscular Dystrophy
NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18 at Peking Union Medical College Hospital (PUMCH...
2025-12-12 21:35
2846
Insilico Medicine and TaiGen Achieves License Agreement to Develop and Commercialize AI-driven PHD Inhibitor for Anemia of Chronic Kidney Disease (CKD)
* Insilico Medicine has licensed TaiGen Biotechnology exclusive rights in the Greater China area to develop, commercialize, and sub-license ISM4808, an AI-driven potential best-in-class oral PHD inhibitor with IND clearance granted in 2023. * The partnership combines Insilico's generative AI ...
2025-12-12 20:00
2418
Smartee Strengthens Clinical Engagement in the DACH Region with First GS Summit in Cologne and Presence at TPAO Congress
COLOGNE, Germany, Dec. 12, 2025 /PRNewswire/ -- Smartee Denti-Technology hosted its first GS-focused clinical summit inCologne on November 27, deepening its collaboration with orthodontists across the DACH region. Although Smartee has operated inGermany for more than 2 years through its local sub...
2025-12-12 17:26
1526
Cadonilimab (PD-1/CTLA-4) Receives FDA Clearance for Global Phase III First-Line Gastric Cancer Trial Versus Nivolumab
HONG KONG, Dec. 11, 2025 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced FDA approval to initiate COMPASSION-37/AK104-311 trial, a global multicenter Phase III trial in gastric cancer evaluating cadonilimab, a first-in-class PD-1/CTLA-4 bispecific antibody. The study wi...
2025-12-12 10:31
3034
Leaders Dental Strengthens Global Competitiveness With CAD/CAM-Based Digital Prosthetics Technology
SEOUL, South Korea, Dec. 12, 2025 /PRNewswire/ -- As the global CAD/CAM-based digital prosthetics market continues to grow rapidly, the importance of laboratories equipped with advanced automation and precision manufacturing capabilities is rising. Leaders Dental Laboratory is enhancing its comp...
2025-12-12 08:00
1195
Mazdutide Demonstrates Significant Weight Loss and Metabolic Benefits in Phase 1b Clinical Trial in Chinese Adolescents with Obesity
* After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with corresponding body weight reductions of 7.72 kg and 8.65 kg. These results were significantly superior to those observed in the placebo group (BMI r...
2025-12-12 08:00
2321
MINDS' Inclusive DIY Christmas Socks by SPED Students Go on Display at Fernvale CC
SINGAPORE, Dec. 12, 2025 /PRNewswire/ -- The Lions Club of Singapore Lotusia, in collaboration with MINDS Raintree Special Student Care Centre (SSCC), hosted "Little Hands, Big Joy", a Christmas celebration designed to bring joy, warmth and meaningful connection to 29 students with intellectual d...
2025-12-12 07:18
1728
FDA Clears NUZ-001 for Entry into HEALEY ALS Platform Trial
Highlights: * FDA has completed their review of the Neurizon NUZ-001 regimen to the HEALEY ALS Platform Trial Master Protocol * This marks the official entry of NUZ-001 as Regimen I in the HEALEY ALS Platform Trial * Next steps include obtaining single IRB approval, site initiations and cl...
2025-12-12 04:49
1954
TraceLink Supports UNICEF's Traceability and Verification System (TRVST) to Advance Safe, Authentic Medicine Access Globally
TraceLink announced its support for UNICEF's Traceability and Verification System (TRVST), a global initiative improving the safety, authenticity, and traceability of medicines in regions vulnerable to falsified or substandard products. By supporting TRVST, TraceLink reinforces its position as th...
2025-12-12 00:21
2805
Suvoda IRT named a Leader in Everest Group's RTSM PEAK Matrix®
CONSHOHOCKEN, Pa., Dec. 11, 2025 /PRNewswire/ -- Suvoda, a global clinical trial technology company, today announced that its IRT (Interactive Response Technology) software, also known as RTSM (Randomization and Trial Supply Management), has been recognized as aLeader in Everest Group's PEAK Matr...
2025-12-12 00:00
1489
Everest Medicines Announces Commercialization Service Agreement and License Agreement with Hasten
- Accretive Commercialization Services Agreement covering six mature assets across critical care, cardiovascular, and metabolic disease leveraging Everest's existing commercial organization - Exclusive Greater China license to develop and commercialize Lerodalcibep, a novel, small protein-bindin...
2025-12-11 23:57
2193
Datasea Announces Breakthrough in Acoustic-Driven Brain-Computer Interface Technology
Developing Healthcare and Intelligent Interaction Through Core Acoustic Innovation BEIJING, Dec. 11, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company"), a global technology enterprise specializing in acoustic high-tech innovations and AI multimodal digital solutions, t...
2025-12-11 22:30
1618
ProPharma Expands Operations with New Office in Hyderabad
Modern workspace supports continued growth and innovation
RALEIGH, N.C., Dec. 11, 2025 /PRNewswire/ -- ProPharma
2025-12-11 21:10
1312
HanchorBio Announces Oral Presentation of HCB101 at the ESMO Immuno-Oncology Congress 2025
International debut underscores emerging role for macrophage checkpoint therapy in gastric cancer, triple-negative breast cancer, and other hard-to-treat solid tumors TAIPEI, SHANGHAI, AND SAN FRANCISCO, Dec. 11, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage biotechn...
2025-12-11 21:00
1551
MATELASER W1 REGEN: The Lightest 24g and Highest 5,100 mW/cm² Wearable Red Light Therapy Device Debuts on Kickstarter
MIAMI, Dec. 11, 2025 /PRNewswire/ -- MATELASER, INC., a pioneer in mobile laser therapy, today announced the official launch of its global crowdfunding campaign for the W1 REGEN, a breakthrough device that brings clinic-grade laser therapy into an ultra-miniature 24g wearable form. Priced at just...
2025-12-11 20:30
1492
The 2nd International Cerebro-cardiovascular Medical Innovation Summit (ICMIS 2025) Opens in Hong Kong: AI Technology and Digital Health Usher in a New Chapter of Translational Medicine.
HONG KONG, Dec. 11, 2025 /PRNewswire/ -- Cerebro-cardiovascular conditions have continued to pose a public health burden. The convergence of population ageing and lifestyle risk factors has made "earlier detection, earlier intervention, and accessible and affordable prevention and management" a c...
2025-12-11 19:19
2041
Life-Space Fiber Jelly: The Fiber Fix Modern Guts Have Been Waiting For
The smarter, tastier way to meet your daily fiber needs, powered by Litesse for smooth digestion and real gut results. KUALA LUMPUR, Malaysia, Dec. 11, 2025 /PRNewswire/ -- In a world where convenience often outweighs nutrition,Life-Space Fiber Jelly steps in the jelly way to gut health and ligh...
2025-12-11 17:57
2491
NovaBridge Presents Positive Ragistomig Phase 1 Dose Expansion Data at ESMO-IO
* Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients with advanced or metastatic solid tumors, including those who have relapsed or are refractory to checkpoint inhibitors, a multi-billion dollar pillar of cancer care, hampered by widespread resistance * The study a...
2025-12-11 14:12
2133
OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
* Collaboration will combine Zealand Pharma's expertise in obesity and metabolic health with OTR Therapeutics' proprietary oral small-molecule platform and strong drug discovery capabilities, to discover and develop novel therapeutics for multiple targets in metabolic diseases * OTR Therapeut...
2025-12-11 14:00
1663
Rhinocare Korea Accelerates Global Expansion with Singapore Joint Venture
K-Healthtech Firm Targets Rapid Global Scale-Up with Drug-Free Nasal-Care Innovation SINGAPORE and SEOUL, South Korea, Dec. 11, 2025 /PRNewswire/ -- Rhinocare Korea, a medtech innovator specializing in drug-free respiratory care, announced plans to establish a joint venture (JV) inSingapore as p...
2025-12-11 12:46
3152
Week's Top Stories
Most Reposted
Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
[Picked up by 311 media titles]
2026-01-15 13:00Colebrook Bosson Saunders Launches Lana: An Adaptable Laptop Stand Engineered for Hybrid Work
[Picked up by 305 media titles]
2026-01-12 16:16
Ready Server Announces Strategic Expansion into Japan with AT TOKYO Data Centre
[Picked up by 301 media titles]
2026-01-13 13:16
CAYIN AI: Revolutionizing Creativity and Global Communication
[Picked up by 300 media titles]
2026-01-12 16:34
JIOS Aerogel® Secures Hyundai Contract Through New Licensing Model
[Picked up by 299 media titles]
2026-01-15 10:00Most Read
CATL Opens Middle East's Largest New Energy Aftermarket Facility in Riyadh
2026-01-11 04:10
4644
Rich Sparkle Holdings Closes Acquisition of TikTok Icon Khaby Lame's Core Company
2026-01-12 04:50
3749
